Rasopathy
Gene: RRAS
Additional unrelated cases with a RASopathy/atypical Noonan syndrome and germline heterozygous variants (presumed GoF, as per mechanism for other RASopathy genes) reported:
- PMID 32815881 (2021): Born with craniosynostosis, mild dysmorphic features and developed MDS with monosomy 7 at age 7. Unable to access additional details (article behind paywall).
- PMID 34935735 (2021): Female born with congenital heart defects (pulmonary subvalvular and valvular stenosis, repaired age 3), presenting age 15 with epistaxia and menorrhagia, followed by MDS with monosomy 7 after two years, complicated by CIDP after allogenic SCT (noted to have 'thickened' nerves, ?myelinisation abnormalities, on pre-SCT CT scan). Normal growth and development, no dysmorphic features. No causative variants on Noonan gene panel or SNP array analysis. De novo heterozygous germline RRAS variant (c.116_118dup, p.(Gly39dup)) detected using trio WES, confirmed by Sanger in DNA from blood sample age 1 (i.e. not a MDS-related somatic variant).
- PMID 39725732 (2024): Cohort study of 149 patients with clinical suspicion of a RASopathy, tested using a 24-gene custom panel. RRAS heterozygous frameshift variant (c.74dup p.(Pro26AlafsTer32), within 5' NMD escape region, but doesn't include the majority of the Ras GTPase domain, ?LoF/GoF, no functional data), detected in a 10-year-old male clinically diagnosed with Noonan; has short stature, dysmorphism (downslanted palpebral fissures, posteriorly rotated ears...see Fig 1e/f), pectus excavatum and borderline ID. Found to be paternally inherited (reported by paper to have 'mild phenotypic features except for intellectual disability', no other details). Cites poster abstract describing an additional atypical Noonan syndrome Turkish case (5-year-old with intestinal lymphangiectasia and prenatal history of hydrops) with this same variant (https://motto.tc/siteler/www.cocukgenetik2019.com/cocuk-genetik-bildiri-kitabi.pdf - P-37, in Turkish!).
Still 'Limited' gene-disease association in ClinGen, but not re-reviewed since original curation in 2018. Updated to Green on PanelApp UK in 2024, based on the 2021 citations above.Created: 13 May 2026, 8:01 p.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Noonan syndrome; Myelodysplastic syndrome
Publications
Mode of pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Additional reports reviewed: one further de novo variant in PMID 34935735; evidence concerns regarding the other two reports, therefore maintain Amber rating.Created: 20 May 2026, 1:20 p.m.
Two individuals reported. One de novo variant, the inheritance of the other variant uncertain. Some supportive functional data. Rated as LIMITED by ClinGen.Created: 3 Jul 2020, 8:09 p.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Noonan syndrome
Publications
Gene: rras has been classified as Amber List (Moderate Evidence).
Phenotypes for gene: RRAS were changed from to Noonan syndrome
Publications for gene: RRAS were set to
Mode of inheritance for gene: RRAS was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Gene: rras has been classified as Amber List (Moderate Evidence).
gene: RRAS was added gene: RRAS was added to Rasopathy_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: RRAS was set to Unknown